MUMBAI, India, June 22 -- Intellectual Property India has published a patent application (202631068684 A) filed by Dr. Sumita Banerjee on June 01, 2026, for Grade-Adaptive Ion Channel-Targeted Electrochemotherapy System For Treatment Of Oral Squamous Cell Carcinoma.
Inventors include Dr. Sumita Banerjee; Dr. Saikat Mukherjee; and Dr. Ashish Ranjan.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present invention relates to a grade-adaptive ion-channel targeted electrochemotherapy system (ICTEU) for treatment of oral squamous cell carcinoma (OSCC). The system comprises a patient interface module with interchangeable electrode probe configurations, a central AI-based control unit configured for tumour grade classification and treatment optimisation, a high-voltage pulse generator for delivery of biphasic electroporation pulses, and a smart drug delivery unit for synchronized administration of chemotherapeutic agents. The system further includes a real-time biofeedback sensor array for monitoring electrical, biochemical, and thermal parameters, and a safety interlock module for adaptive control and emergency shutdown. The AI control unit enables grade-specific selection of electrode geometry, pulse parameters, and drug regimens to achieve targeted ion-channel mediated electropermeabilisation. The invention provides improved treatment precision, enhanced therapeutic efficacy, reduced systemic toxicity, and real-time adaptive safety control for localized management of OSCC in oral anatomical regions. (Reference Figure 1)
Disclaimer: Curated by HT Syndication.
